Prosecution Insights
Last updated: April 19, 2026

Abiogen Pharma S P A

2 pending office actions

Portfolio Summary

2
Total Pending OAs
2
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18192094 USE OF NERIDRONIC ACID OR OF ITS SALT FOR THE TREATMENT OF OSTEOARTHROSIS OTTON, ALICIA L 1699 Final Rejection Mar 29, 2023
17632841 CHOLECALCIFEROL FOR USE IN THE TREATMENT OF CELIAC DISEASE MCMILLIAN, KARA RENITA 1623 Final Rejection Feb 04, 2022

Managing Abiogen Pharma S P A's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month